Blackstone’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
Other funds holding AEON
CCA
Blackstone's AEON Position: Q1 2023 in Review
Blackstone sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 558 shares — an estimated $403K sold.
Blackstone first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $4.87M in Q3 2021. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.
- Blackstone reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
- Blackstone sold 558 AEON Biopharma shares in Q1 2023, an estimated $403K.
- Blackstone first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
- Blackstone's AEON Biopharma position peaked at $4.87M in Q3 2021.
- 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.
Based on Blackstone's 13F filing for Q1 2023, filed 15 May 2023.